Immunpharmacology Flashcards
Time for development of primary immune response…
Activation of T cells and AB production takes…
8-14d
1-3d
Basophils release…
- histamine
- bradykinin
- serotonin
- heparin
- SRSA
Immunosuppressants generally work better for______
primary immune response
Acute rejection is mainly mediated by ____ and ___
T cells and cytokines
Three routes of immunosuppression
- Decrease amount of lymphocyte
- Divert lymphocyte traffic
- Block pathways involved in lymphocytic response
6 catergories of immunosuppressants
- regulators of gene expression
- alkylating agents
- inhibitors of de novo pyrimidine synth
- inhibitors of de novo purine synth
- Kinase + phosphatase inhibitors
- Protein immunosuppressive drugs
Adrenocortical steroid MOA (3)
- reduce levels of lymphocytes
- Block antigen presentation pathway
- Inhibit IL-2 gene transcription whih is needed for B and T cell clonal expansion
Example of alkylating agent
cyclophosphamide (cytotoxic)
Examples of first and second generation inhibitors of de novo purine synthesis
1st gen = AZT + 6-Mercaptopurine
2nd Gen = mizoribine + mycophenolate mofetil
What is MMF
inosine 5-MP dehydrogenase inhibitor
Methotrexate and polygentamate derivatives also belong to which class of drugs?
Purine synthesis inhibitors
Alkylating agents and Purine synthesis inhibitors – how to they induce/maintain immunosuppression
Block DNA/RNA synth
Prevent clonal expansion of B/T cells
Examples of Pyrimidine inhibitors
What is the MOA?
- Brequinar
- Leflunomide
- malononitrilomides
inhibit dihydroorotate dehydrogenase
Kinase and phosphatase inhibitor drugs
Cyclosporine and tacrolimus
Cyclosporine concentrates in _____
It is given ___ prior to ____
**MOA?**
Red/white cells
give 4-24h before transplant
Inhibits the phosphatase activity of calcineurin
= prevents NFAT translocation
**also blocks JNK and p38 signaling
Tacrolimus category and MOA
macrolide
binds to FK506-BP 12
= inhibits the phosphatase activity of calcineurin
Sirolimus MOA
What is unique?
Binds FKBP12
(same as tacrolimus)
Complex formation with FKBP12 does not inhibit IL-2 production
Antilymphocyte globulins (protein immunosuppressives)
muromonab-CD3
Daclizumab
Basiliximab
AntiCD25 mAb’s
Daclizumab and Basiliximab
Anti CD3 mAb that binds to TCR-associated CD3 complex and alters T cells
Muromonab